These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8691311)

  • 1. CD 105 and angiogenesis.
    Kumar P; Wang JM; Bernabeu C
    J Pathol; 1996 Apr; 178(4):363-6. PubMed ID: 8691311
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiogenesis in breast cancer: the role of transforming growth factor beta and CD105.
    Li C; Guo B; Bernabeu C; Kumar S
    Microsc Res Tech; 2001 Feb; 52(4):437-49. PubMed ID: 11170303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endoglin is expressed in the chicken vasculature and is involved in angiogenesis.
    Raab U; Lastres P; Arévalo MA; López-Novoa JM; Cabañas C; de la Rosa EJ; Bernabéu C
    FEBS Lett; 1999 Oct; 459(2):249-54. PubMed ID: 10518029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoglin: An accessory component of the TGF-beta-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies.
    Fonsatti E; Del Vecchio L; Altomonte M; Sigalotti L; Nicotra MR; Coral S; Natali PG; Maio M
    J Cell Physiol; 2001 Jul; 188(1):1-7. PubMed ID: 11382917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective angiogenesis in mice lacking endoglin.
    Li DY; Sorensen LK; Brooke BS; Urness LD; Davis EC; Taylor DG; Boak BB; Wendel DP
    Science; 1999 May; 284(5419):1534-7. PubMed ID: 10348742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis and hereditary hemorrhagic telangiectasia. Rendu-Osler-Weber disease.
    Sabbà C; Cirulli A; Rizzi R; Pasculli G; Gallitelli M; Specchia G; Liso V
    Acta Haematol; 2001; 106(4):214-9. PubMed ID: 11815719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signaling by the transforming growth factor-beta receptors.
    Yingling JM; Wang XF; Bassing CH
    Biochim Biophys Acta; 1995 Dec; 1242(2):115-36. PubMed ID: 7492567
    [No Abstract]   [Full Text] [Related]  

  • 8. Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels.
    Fonsatti E; Altomonte M; Nicotra MR; Natali PG; Maio M
    Oncogene; 2003 Sep; 22(42):6557-63. PubMed ID: 14528280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD105 (endoglin), apoptosis, and stroke.
    Guo B; Kumar S; Li C; Slevin M; Kumar P
    Stroke; 2004 May; 35(5):e94-5. PubMed ID: 15060327
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Role of transforming growth factor-beta signaling in cancer.
    Li C; Garland JM; Kumar S
    J Natl Cancer Inst; 2001 Apr; 93(7):555-7. PubMed ID: 11287452
    [No Abstract]   [Full Text] [Related]  

  • 11. CD105 antagonizes the inhibitory signaling of transforming growth factor beta1 on human vascular endothelial cells.
    Li C; Hampson IN; Hampson L; Kumar P; Bernabeu C; Kumar S
    FASEB J; 2000 Jan; 14(1):55-64. PubMed ID: 10627280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of tumour neovasculature by targeting the TGF-beta binding receptor endoglin.
    Bredow S; Lewin M; Hofmann B; Marecos E; Weissleder R
    Eur J Cancer; 2000 Mar; 36(5):675-81. PubMed ID: 10738134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of endoglin (CD105) expression during childhood brain tumor-related angiogenesis. Anti-angiogenic therapy.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1998; 18(3A):1485-500. PubMed ID: 9673360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoglin expression in early development is associated with vasculogenesis and angiogenesis.
    Jonker L; Arthur HM
    Mech Dev; 2002 Jan; 110(1-2):193-6. PubMed ID: 11744382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemical detection of endoglin is indicative of angiogenesis in malignant melanoma.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1998; 18(4A):2701-10. PubMed ID: 9703932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Over-expression of endoglin (CD105): a marker of breast carcinoma-induced neo-vascularization.
    Bodey B; Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1998; 18(5A):3621-8. PubMed ID: 9858949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endoglin: A marker of neoplasias or rather of neo-angiogenesis?
    Barresi V; Barresi G
    Head Neck; 2010 Jul; 32(7):970-1; author reply 971. PubMed ID: 20552608
    [No Abstract]   [Full Text] [Related]  

  • 18. Endoglin is a component of the transforming growth factor (TGF)-beta receptor complex of human pre-B leukemic cells.
    Zhang H; Shaw AR; Mak A; Letarte M
    J Immunol; 1996 Jan; 156(2):564-73. PubMed ID: 8543807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and possible function of endoglin, a TGF-beta binding protein.
    Westphal JR; Willems HW; Schalkwijk CJ; Ruiter DJ; De Waal RM
    Behring Inst Mitt; 1993 Aug; (92):15-22. PubMed ID: 8250809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-lasting complete inhibition of human solid tumors in SCID mice by targeting endothelial cells of tumor vasculature with antihuman endoglin immunotoxin.
    Seon BK; Matsuno F; Haruta Y; Kondo M; Barcos M
    Clin Cancer Res; 1997 Jul; 3(7):1031-44. PubMed ID: 9815781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.